Stay updated on Pembrolizumab in HER2+ Gastric Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.

Latest updates to the Pembrolizumab in HER2+ Gastric Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now includes sponsor and IPD sharing information, including links and plan details, as well as references to the study protocol and statistical analysis plan. Expanded keyword and MeSH term metadata for the trial now appears on the page.SummaryDifference100%

- Check18 days agoChange DetectedThe Plain Language Summary section was removed from the page, removing a user-friendly explanation of the study's purpose and key details.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a maintenance release for the study record display. This update appears to be a backend or UI refinement rather than a change to study data.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now displays a new revision label, Revision: v3.6.3, replacing the older Revision: v3.6.0. This indicates a page version update, likely involving minor documentation or formatting adjustments.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now shows recruitment is closed ('No longer looking for participants'); it also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention label to Intervention/Treatment as well as the revision tag to v3.6.0.SummaryDifference0.1%

- Check76 days agoChange DetectedUpdated the page revision from v3.5.4 to v3.5.5, indicating a new version of the record. This reflects backend/editorial updates rather than changes to the trial data or public information.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in HER2+ Gastric Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.